Higher exhaled nitric oxide levels in infancy is associated with less bronchiolitis and fewer adverse respiratory outcomes in the first year of life

C. Da Silva Sena (Newcastle, Australia), E. De Queiroz Andrade (Newcastle, Australia), P. De Gouveia Belinelo (Newcastle, Australia), E. Percival (Newcastle, Australia), B. Prangemeier (Newcastle, Australia), C. O’Donoghue (Newcastle, Australia), S. Terry (Newcastle, Australia), T. Burke (Newcastle, Australia), W. Gunning (Newcastle, Australia), V. Murphy (Newcastle, Australia), P. Robinson (Sydney, Australia), P. Sly (South Brisbane, Australia), P. Gibson (Newcastle, Australia), A. Collison (Newcastle, Australia), J. Mattes (Newcastle, Australia)

Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Session: Biomarkers and risk factors in childhood asthma
Session type: E-poster
Number: 3069

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Da Silva Sena (Newcastle, Australia), E. De Queiroz Andrade (Newcastle, Australia), P. De Gouveia Belinelo (Newcastle, Australia), E. Percival (Newcastle, Australia), B. Prangemeier (Newcastle, Australia), C. O’Donoghue (Newcastle, Australia), S. Terry (Newcastle, Australia), T. Burke (Newcastle, Australia), W. Gunning (Newcastle, Australia), V. Murphy (Newcastle, Australia), P. Robinson (Sydney, Australia), P. Sly (South Brisbane, Australia), P. Gibson (Newcastle, Australia), A. Collison (Newcastle, Australia), J. Mattes (Newcastle, Australia). Higher exhaled nitric oxide levels in infancy is associated with less bronchiolitis and fewer adverse respiratory outcomes in the first year of life. 3069

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is exhaled nitric oxide in newborns associated with subsequent respiratory symptoms in infancy?
Source: Eur Respir J 2006; 28: Suppl. 50, 269s
Year: 2006

Low exhaled nitric oxide levels in infants with respiratory symptoms in the first 2 months of life
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


Elevated exhaled nitric oxide as a predictor of school absence after hospitalisation with acute wheeze
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Factors associated with elevated exhaled nitric oxide fraction in infants with recurrent respiratory symptoms
Source: Eur Respir J 2013; 41: 189-194
Year: 2013



Elevated exhaled nitric oxide and risk of wheezing in infancy. The generation R study
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009

Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence
Source: Eur Respir J 2016; 47: 510-519
Year: 2016



Exhaled nitric oxide measured after birth predicts subsequent respiratory infections in infants
Source: Eur Respir J 2002; 20: Suppl. 38, 21s
Year: 2002

Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008



Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Smoke exposure, airway symptoms and exhaled nitric oxide in infants: the Generation R study
Source: Eur Respir J 2008; 32: 307-313
Year: 2008



Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD
Source: Eur Respir J, 51 (1) 1701457; 10.1183/13993003.01457-2017
Year: 2018



Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Rint, exhaled nitric oxide and the prediction of asthma and respiratory symptoms in children
Source: Eur Respir J 2005; 26: Suppl. 49, 479s
Year: 2005

Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020



Infant exhaled nitric oxide does not identify persistent wheezers by the age of four years
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


Exhaled nitric oxide as the sole determinant of therapy in all obstructive patients in a primary care setting: long-lasting effects on health related quality of life
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007


High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010